Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Tianyin Pharma Completes Antibiotic Facility

publication date: Jan 28, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Tianyin Pharmaceutical completed construction of its Jiangchuan macrolide facility in the Xinjin Industrial Development Area, near Chengdu, China. The company says it expects the plant to add revenues during its 2011 fiscal year. In its Phase I state, the facility is capable of producing up to 240 tons of azithromycin API for domestic and international markets. More details....

Stock Symbol: (NYSE Amex: TPI)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors